• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Aakaar Medical Technologies Limited — Important, 11-02-2026: Product launch

    11-02-2026 | 06:26 pm

    Aakaar Medical Technologies launches Letybo, a USFDA-approved botulinum toxin, for the Indian market. This strategic move into the high-growth medical aesthetics segment boosts credibility and aims for deeper market penetration via flexible pricing.

    No comments yet. Be the first to comment!

    All announcements from Aakaar Medical Technologies Limited